Jong Ho Chun

520 total citations
21 papers, 417 citations indexed

About

Jong Ho Chun is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Jong Ho Chun has authored 21 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Jong Ho Chun's work include Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (6 papers). Jong Ho Chun is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers) and Cancer Treatment and Pharmacology (6 papers). Jong Ho Chun collaborates with scholars based in South Korea, United States and Ethiopia. Jong Ho Chun's co-authors include Il Ju Choi, Curt I. Civin, Shelly Heimfeld, Alan D. Friedman, Xiaobing Yu, Jonathan K. Alder, Linzhao Cheng, Jae-Moon Bae, Hark Kyun Kim and Young‐Woo Kim and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Jong Ho Chun

19 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jong Ho Chun South Korea 10 203 199 130 114 43 21 417
Yasumichi Yagi Japan 9 131 0.6× 137 0.7× 94 0.7× 121 1.1× 27 0.6× 20 339
Yasunori Deguchi Japan 10 153 0.8× 160 0.8× 104 0.8× 110 1.0× 43 1.0× 16 352
Eugene A. Choi United States 10 257 1.3× 106 0.5× 137 1.1× 137 1.2× 65 1.5× 17 491
Myoung Won Son South Korea 10 101 0.5× 101 0.5× 68 0.5× 61 0.5× 54 1.3× 35 261
Weisong Shen China 14 147 0.7× 274 1.4× 94 0.7× 194 1.7× 85 2.0× 30 548
Motoshi Miyagi Japan 12 113 0.6× 211 1.1× 124 1.0× 145 1.3× 45 1.0× 28 373
Jiadi Xing China 14 187 0.9× 214 1.1× 150 1.2× 164 1.4× 110 2.6× 48 509
Masami Mitani Japan 8 220 1.1× 98 0.5× 262 2.0× 95 0.8× 49 1.1× 23 470
Jiun‐Yi Hsia Taiwan 14 157 0.8× 252 1.3× 210 1.6× 173 1.5× 82 1.9× 40 598
Marek Olakowski Poland 13 244 1.2× 121 0.6× 106 0.8× 239 2.1× 57 1.3× 40 427

Countries citing papers authored by Jong Ho Chun

Since Specialization
Citations

This map shows the geographic impact of Jong Ho Chun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jong Ho Chun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jong Ho Chun more than expected).

Fields of papers citing papers by Jong Ho Chun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jong Ho Chun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jong Ho Chun. The network helps show where Jong Ho Chun may publish in the future.

Co-authorship network of co-authors of Jong Ho Chun

This figure shows the co-authorship network connecting the top 25 collaborators of Jong Ho Chun. A scholar is included among the top collaborators of Jong Ho Chun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jong Ho Chun. Jong Ho Chun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chun, Jong Ho, et al.. (2006). Phase II study of docetaxel and irinotecan combination chemotherapy in metastatic gastric carcinoma. British Journal of Cancer. 94(10). 1402–1406. 19 indexed citations
4.
Lee, Jae Jin, Ji‐Youn Han, Dae Ho Lee, et al.. (2006). A Phase II Trial of Docetaxel Plus Capecitabine in Patients with Previously Treated Non-Small Cell Lung Cancer. Japanese Journal of Clinical Oncology. 36(12). 761–767. 12 indexed citations
5.
Yu, Xiaobing, Jonathan K. Alder, Jong Ho Chun, et al.. (2006). HES1 Inhibits Cycling of Hematopoietic Progenitor Cells via DNA Binding. Stem Cells. 24(4). 876–888. 93 indexed citations
6.
Park, Sook Ryun, Jong Ho Chun, Young‐Woo Kim, et al.. (2005). Phase II Study of Low-Dose Docetaxel/Fluorouracil/Cisplatin in Metastatic Gastric Carcinoma. American Journal of Clinical Oncology. 28(5). 433–438. 32 indexed citations
7.
Chun, Jong Ho, Hark Kyun Kim, Jong Seok Lee, et al.. (2005). Weekly Docetaxel in Combination With Capecitabine in Patients With Metastatic Gastric Cancer. American Journal of Clinical Oncology. 28(2). 188–194. 46 indexed citations
8.
Lim, Hyeong‐Seok, et al.. (2005). A phase II study of docetaxel (T) and capecitabine (X) combination chemotherapy as first-line chemotherapy for patients (pts) with metastatic breast cancer (MBC). Journal of Clinical Oncology. 23(16_suppl). 889–889. 1 indexed citations
9.
Kim, Hark Kyun, Il Ju Choi, Hee Sung Kim, et al.. (2004). DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer. Biochemical and Biophysical Research Communications. 316(3). 781–789. 27 indexed citations
10.
Chun, Jong Ho. (2004). Weekly Irinotecan in Patients with Metastatic Gastric Cancer Failing Cisplatin-based Chemotherapy. Japanese Journal of Clinical Oncology. 34(1). 8–13. 62 indexed citations
11.
Chun, Jong Ho, et al.. (2004). Frontline docetaxel (T)/ capecitabine (X) combination therapy in patients (pts) with metastatic breast cancer (MBC): A phase II study. Journal of Clinical Oncology. 22(14_suppl). 778–778. 3 indexed citations
12.
13.
Chun, Jong Ho, et al.. (2004). Frontline docetaxel (T)/ capecitabine (X) combination therapy in patients (pts) with metastatic breast cancer (MBC): A phase II study. Journal of Clinical Oncology. 22(14_suppl). 778–778. 4 indexed citations
14.
15.
Lee, Dae Ho, Eun Kyung Hong, Sung Min Yoon, et al.. (2003). A phase II study of weekly docetaxel plus capecitabine for patients with advanced nonsmall cell lung carcinoma. Cancer. 98(9). 1918–1924. 27 indexed citations
16.
Han, Ji‐Youn, Dae Ho Lee, Jong Ho Chun, et al.. (2003). P-230 A phase II study of weekly docetaxel plus capecitabine for patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer. 41. S149–S149. 1 indexed citations
17.
Kim, Ju Han, Myung Ho Jeong, Jay Young Rhew, et al.. (2003). The Long-Term Clinical Outcomes of Low Molecular Weight Heparin Combined with Platelet Glycoprotein IIb/IIIa Inhibitor in Patients with Acute Coronary Syndrome. Sunhwan'gi. 33(7). 559–559. 4 indexed citations
18.
19.
Chun, Jong Ho, et al.. (1997). A Study of 162 Cases of Peri-Ampullary Diverticulum.. Korean Journal of Gastrointestinal Endoscopy. 17(6). 778–788. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasumichi Yagi Breakdown of academic impact, for papers by Yasunori Deguchi Breakdown of academic impact, for papers by Eugene A. Choi Breakdown of academic impact, for papers by Myoung Won Son Breakdown of academic impact, for papers by Weisong Shen Breakdown of academic impact, for papers by Motoshi Miyagi Breakdown of academic impact, for papers by Jiadi Xing Breakdown of academic impact, for papers by Masami Mitani Breakdown of academic impact, for papers by Jiun‐Yi Hsia Breakdown of academic impact, for papers by Marek Olakowski
Rankless by CCL
2026